在 RhD 阴性妇女进行第一季度堕胎时进行 rhesus 检测和抗D 预防-系统性审查和意见
Kristina Gemzell-Danielsson1,2, Sharon Cameron3, Teresa Bombas4
1Division of Obstetrics and Gynecology, Department of Women's and Children's Health, Karolinska Institutet, Stockholm, Sweden.
概括
最近的指导方针建议在第一季度堕胎的RhD阴性妇女不使用免疫球蛋白G (IgG) 抗D预防. 本综述分析了证据,以支持有关 RhD 检测和预防的知情临床决策.
科学领域:
- 产科和妇科 产科和妇科
- 免疫学 免疫学 免疫学
- 围产儿医学 围产儿医学
背景情况:
- 免疫球蛋白G (IgG) 抗D预防显著降低了RhD与胎儿和新生儿的免疫和溶血性疾病.
- 在第一季度堕胎中,常规抗D预防的证据有限.
- 目前的做法各不相同,需要对指导方针和文献进行审查.
研究的目的:
- 分析国际和国家基于证据的关于Rh测试和抗D预防的指导方针.
- 审查支持或反对这种做法的文献.
- 为了促进知情的临床决策.
主要方法:
- 从2003年到2024年,对多个数据库 (PubMed,EMBASE,Cochrane,Google Scholar) 的系统文献搜索.
- 包括指南,评论,元分析,观察性研究,RCT,现实数据和队列研究.
- 由两位作者进行的独立选和数据提取.
主要成果:
- 最近的指导方针 (例如,世卫组织,2022年以后) 建议在第一季度堕胎时不使用抗D.
- 较旧的指导方针经常建议在12周之前进行RhD测试和抗D预防,怀孕年龄值各不相同.
- 差异源于不同的证据解释,可用性和社会法律因素.
结论:
- 需要基于证据的,协调的指导方针,关于IgG抗D在第一季度堕胎的预防.
- 医疗保健提供者必须随时了解最新的建议.
- 与患者共享决策对于管理经历RhD阴性妇女的第一季度堕胎至关重要.
更多相关视频
相关概念视频
Rh Blood Group
1.8K
The Rhesus (Rh) antigen is crucial in determining blood groups and ensuring compatibility during blood transfusions.
1.8K
Rheumatic Heart Disease III: Medical Management
32
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
32
Blood Typing
1.5K
Understanding an individual's blood group is a critical component of transfusion medicine. It ensures compatibility in blood transfusions, organ transplants, and even during pregnancy. Determining these blood groups involves the ABO and Rh blood typing systems, utilizing specific antigens and corresponding anti-sera to identify an individual's blood type.
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
Antigens are protein molecules that reside on the surface of red blood cells (RBCs). The ABO and Rh blood typing systems target...
1.5K
Rheumatic Heart Disease II: Clinical Manifestations and Diagnostic Studies
59
The key clinical manifestations of Rheumatic heart disease (RHD) include several distinct cardiac symptoms.Carditis, a hallmark of acute rheumatic fever, involves inflammation of the heart's endocardium, myocardium, and pericardium. Chronic RHD often results from recurrent episodes of carditis. Its symptoms include the following:Murmurs are caused by valvular damage, especially to the mitral and aortic valves. Mitral stenosis or regurgitation is common, with characteristic heart murmurs...
59
Rheumatic Heart Disease IV: Nursing Management
38
AssessmentA comprehensive assessment is essential in managing a patient with rheumatic heart disease (RHD). Begin with obtaining a detailed medical history, including recent streptococcal infections, a history of rheumatic fever, or previously diagnosed rheumatic heart disease. Assess the patient for symptoms such as fever, chest pain, widespread joint pain (arthralgia), tachycardia, pericardial friction rub, muffled heart sounds, heart murmurs, peripheral edema, subcutaneous nodules, and...
38
Blood Transfusion and Agglutination
11.2K
Blood transfusion is a therapeutic measure to restore the blood volume after extensive blood loss due to an accident or a medical procedure. Blood transfusion involves drawing a certain amount of blood from a suitable donor and infusing it into the recipient.
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
History
The history of blood transfusion dates back to the 17th century, when early attempts were made in animals. In 1818 James Blundell, a British doctor, performed the first successful human blood transfusion. Later in 1900, Karl...
11.2K


